Nagatsuka Motoki, Asai Tohru, Noguchi Kenichiro, Hama Daisuke, Arai Chishio
Department of Cardiovascular Surgery, Shonan Kamakura General Hospital, Kamakura, JPN.
Cureus. 2025 Feb 19;17(2):e79320. doi: 10.7759/cureus.79320. eCollection 2025 Feb.
Cardiac surgery in patients with myelodysplastic syndrome (MDS) is difficult because extracorporeal circulation increases the risk of infection and hemorrhage. We discuss the efficacy of venovenous extracorporeal membrane oxygenation (VV-ECMO) in managing intraoperative alveolar hemorrhage in a patient with MDS undergoing minimally invasive cardiac surgery (MICS) for mitral valve repair. A 76-year-old man with MDS underwent mitral valve repair via right minithoracotomy with standard cardiopulmonary bypass. Left lung hemorrhage developed after declamping of the aorta, and oxygenation support was necessary when the cardiopulmonary bypass was finished, as a bridge until hemostasis. VV-ECMO was established, which involves withdrawing blood from the right femoral vein and returning it via the right internal jugular vein. Platelet transfusion and protamine were administered. Hemostasis was achieved, and the patient was admitted to the intensive care unit without mechanical circulatory support. VV-ECMO proved successful for MICS with hemorrhagic pulmonary complications.
骨髓增生异常综合征(MDS)患者的心脏手术具有挑战性,因为体外循环会增加感染和出血风险。我们讨论了静脉-静脉体外膜肺氧合(VV-ECMO)在一名接受二尖瓣修复的微创心脏手术(MICS)的MDS患者术中肺泡出血管理中的疗效。一名76岁的MDS男性患者通过右胸小切口经标准体外循环进行二尖瓣修复。主动脉夹闭解除后出现左肺出血,体外循环结束后需要氧合支持作为止血前的过渡。建立了VV-ECMO,即从右股静脉抽血并通过右颈内静脉回输。输注了血小板和鱼精蛋白。实现了止血,患者在没有机械循环支持的情况下被收入重症监护病房。VV-ECMO被证明在伴有出血性肺部并发症的MICS中是成功的。